Jing Zhang
Program & Alliance Management, Alnylam Pharmaceuticals
Enrollment Year - 2005
Roberts Lab - Dana-Farber Cancer Institute
Advisor: Tom Roberts
Dissertation Title: CRKL is an important regulator of PI3K signaling in PTEN-deficient tumors.